Biofourmis Expands into Virtual Specialty Care with the Launch of Biofourmis Care

First of its kind service combines a specialized, multidisciplinary clinical care team with an AI-enabled care management platform for automated medication management, earlier interventions and improved outcomes BOSTON, February 9, 2022 – Biofourmis, a Boston-based global leader in virtual care and digital therapeutics, announced today the launch of Biofourmis Care, a first of its kind, […]

UCI Health Partners with Biofourmis for Hospital at Home and Post-Acute Remote Patient Monitoring

Leading U.S. academic medical center to deliver hospital-level care in patients’ homes and continuous monitoring of recently discharged patients using the Biofourmis platform BOSTON – February 2, 2022 – Biofourmis, a Boston-based global leader in digital therapeutics and virtual care that powers personalized predictive care, announced today a multi-year agreement with UCI Health to support […]

Biofourmis Wins Two 2021 Fierce Healthcare Innovation Awards for Hospital@Home Solution

Comprehensive, turnkey platform that delivers inpatient-level care at home earns recognition for “Digital/Mobile Health Solution” and “Best in Show: Cost Saving” BOSTON, December 13, 2021 – Biofourmis, a Boston-based global leader in digital therapeutics and virtual care that powers personalized predictive care, today announced that its Hospital@Home solution has been named by Fierce Healthcare as […]

Integra Community Care Network Partners with Biofourmis to Deliver Personalized Care at Home

Care New England to continuously monitor patients across a variety of conditions with Biofourmis’ proven technology, offering predictive insight to Integra clinicians PROVIDENCE, R.I., October 14, 2021 – Biofourmis, a Boston-based global leader in digital therapeutics and virtual care that powers personalized predictive care, announced today a partnership with Integra Community Care Network, Care New […]

Biofourmis Named 2021 DPHARM Idol Disrupt Winner

11th Annual Award Judged by Pharma and Life Sciences Leaders Recognizes Disruptive Innovations to Advance Clinical Research BOSTON, October 11, 2021 – Biofourmis, a Boston-based global leader in digital therapeutics and virtual care that powers personalized predictive care, has been named the winner of the 2021 DPHARM Idol Disrupt event. The award recognizes disruptive innovations […]

Biofourmis Earns FDA’s First-Ever Breakthrough Device Designation for a Novel Digital Therapeutic for Heart Failure

BiovitalsHF® Approved for Expedited FDA Review Process as a First-in-Class DTx for Heart Failure that Augments Traditional Guideline-Directed Medical Therapy BOSTON, July 29, 2021 – Biofourmis, a Boston-based global leader in virtual care and digital therapeutics, announced today its BiovitalsHF® solution is the first-ever heart failure digital therapeutic to receive a Breakthrough Device designation from […]

Global Healthcare Leader Joins Biofourmis as Chief Commercial Officer

Sheeza Khawar Hussain to Accelerate Market Growth for Biofourmis’ Care-at-Home Technology Solutions, including Hospital at Home    BOSTON, June 23, 2021 – Biofourmis, a Boston-based global leader in virtual care and digital therapeutics, has named global healthcare marketing and sales leader Sheeza Khawar Hussain as its first-ever chief commercial officer (CCO). Her appointment comes at […]

Digital Health Leader Maulik Majmudar, MD, Joins Biofourmis as Chief Medical Officer to Accelerate Company’s Move to Become the Most Comprehensive Care-at-Home Platform

Former Amazon Medical Officer and Massachusetts General Hospital Cardiologist to Lead Product Management, Data Science and Clinical Affairs for Fast-Growing Tech-Enabled Care Delivery Company BOSTON, May 10, 2021 /PRNewswire/ — Biofourmis, a Boston-based global leader in virtual care and digital therapeutics, has named Maulik Majmudar, MD, a cardiologist and leader in digital health transformation, as its chief medical officer. Dr. […]

Biofourmis Announces National Rollout of the Biovitals® Hospital@Home™ Platform to Help Deliver Hospital-Level Care in the Home Aligned with New CMS Program

– To immediately expand hospital capacity during the COVID-19 public health emergency, CMS has announced the Acute Hospital at Home program waiver that provides full inpatient reimbursement for acutely ill patients cared for at home – The Hospital@HomeTM platform provides a turnkey, end-to-end ecosystem for any health system that wants to quickly launch a hospital at home […]

Biofourmis Closes $100 Million Series C Funding Round Led by SoftBank Vision Fund 2 to Accelerate U.S. and Global Expansion

Funding to advance “home hospital” initiatives with health systems and “beyond the pill” digital therapeutics partnerships with pharmaceutical companies BOSTON, Sept. 3, 2020 /PRNewswire/ — Biofourmis, a fast-growing global leader in digital therapeutics that powers personalized predictive care, has announced the completion of a $100 million Series C financing round led by SoftBank Vision Fund 2,[1] with participation by existing investors […]

Biofourmis’ AI-Powered Remote Monitoring Platform Deployed to Monitor COVID-19 Patients in Singapore

– COVID-19 patients in Singapore are being monitored using Biofourmis’ cutting-edge wearable and artificial intelligence technology to accelerate disease surveillance and interventions – Biofourmis staff support clinicians and nurses to implement the program and provide 24/7 technical assistance to patients to increase adherence to monitoring program   BOSTON and SINGAPORE, July 29, 2020 /PRNewswire/ — and July 30, 2020 – Biofourmis , a […]

Chugai and Biofourmis Partner to Develop an Objective Assessment of Pain Using Digital Technology

– Chugai and Biofourmis are partnering to develop a digital solution leveraging Biofourmis’ Biovitals® platform for pain management in patients with endometriosis – A non-interventional study will be conducted with endometriosis patients to validate the novel tool in real-life conditions   TOKYO and BOSTON, July 21, 2020 /PRNewswire/ — and July 22, 2020 – Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) and Biofourmis, a Boston-based digital […]

Biofourmis names new CFO to help drive the digital therapeutics start-up’s growth plans

Finance leader Matt Borowiecki brings deep M&A and fundraising experience to his new role   BOSTON, May 26, 2020 /PRNewswire/ — Biofourmis, a fast-growing global leader in digital therapeutics that powers personally predictive care, has named Matt Borowiecki its Chief Financial Officer (CFO) to enhance decision-making related to future strategic investments, and to expand the company’s forecasting capabilities and financial […]

Digital Therapeutics Leader Biofourmis Expands into Oncology Market with Strategic Acquisition of Gaido Health

Acquisition of Gaido Health from Takeda Digital Ventures builds Biofourmis’ digital therapeutics portfolio in oncology, while improving the care experience for cancer patients and providers   BOSTON, April 16, 2020 /PRNewswire/ — Biofourmis, a global leader in digital therapeutics that powers personalized predictive care, announced today it has finalized an agreement to acquire Gaido Health from Takeda Pharmaceuticals, […]

Biofourmis’ AI-Powered Remote Monitoring Platform to Provide New Insights to Fight COVID-19 in Disease Monitoring Program in Hong Kong

– First-of-its-kind program administered by The University of Hong Kong has international implications and applications as COVID-19 continues to spread – Clinicians to leverage Biofourmis’ cutting-edge wearable and artificial intelligence technology to accelerate disease surveillance and interventions – Biofourmis’ technology will remotely monitor coronavirus infected and suspected patients and apply personalized predictive analytics to help […]

Biofourmis Partners with ImagineMIC to Pioneer Collaborative Remote Patient Monitoring Model

Biofourmis’ artificial intelligence-powered RhythmAnalytics® to provide clinical decision support that IDs cardiac arrhythmias and other issues requiring intervention BOSTON, Jan. 30, 2020 /PRNewswire/ — Biofourmis, a fast-growing global leader in digital therapeutics that powers personally predictive care, and ImagineMIC™ announced a partnership agreement today to drive improved outcomes and lower healthcare costs for patients with chronic conditions. ImagineMIC™ […]

Biofourmis Names Pharma and Tech Veterans as COO and CTO

COO Jaydev Thakkar brings deep clinical trial and digital therapeutics experience; CTO Milan Shah is a former Microsoft developer who has grown and sold four technology companies   BOSTON, Jan. 27, 2020 /PRNewswire/ — Biofourmis, a fast-growing global leader in digital therapeutics that powers personally predictive care, has named two highly experienced and skilled business leaders with deep, […]

Biofourmis Forms Alliance With Global Healthcare Company To Offer Digital Therapeutics For Patients With Heart Failure

– Novartis to leverage Biofourmis’ lead digital therapeutics product to remotely manage patients with heart failure across Asia – Alliance combines Novartis access solutions for patients with heart failure and Biofourmis’ expertise in digital therapeutics – Novartis continues to pioneer in leveraging digital technologies to deliver better clinical and economic outcomes for patients with heart […]

Biofourmis Announces Acquisition of Biovotion AG, Completing Biovitals® Platform to Deliver Precise Interventions at the Right Time to Manage Patients with Complex Chronic Conditions

Acquisition of Biovotion establishes Biovitals® as the most comprehensive predictive digital therapeutics solution for healthcare providers, payers and pharmaceutical companies by combining best-in-class medical data collection and digital therapeutics solutions into one platform   BOSTON and ZÜRICH, Nov. 18, 2019 /PRNewswire/ — Biofourmis, a fast-growing global leader in digital therapeutics based in Boston, announced today it has reached an agreement […]

Biofourmis’ Biovitals™ Analytics Engine Receives FDA Clearance for Ambulatory Physiologic Monitoring

Milestone approval establishes AI-powered solution as the foundation for future disease-specific predictive management tools from Biofourmis   BOSTON, Oct. 3, 2019 /PRNewswire/ — Biofourmis, a fast-growing global leader in digital therapeutics, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its machine-learning and artificial intelligence (AI)-powered Biovitals™ Analytics Engine as a medical device for […]

Biofourmis Named to the 2019 CB Insights Digital Health 150 List of Most Innovative Digital Health Startups

CEO Kuldeep Singh Rajput will also speak at CB Insights’ Future of Health conference about what’s ahead for digital therapeutics   NEW YORK, Oct. 2, 2019 /PRNewswire/ — CB Insights announced today at its Future of Health conference that Biofourmis, a Boston-based fast-growing global leader in digital therapeutics, has been named to the organization’s inaugural Digital Health 150 ranking, which showcases the 150 most […]

Digital therapeutics leader Biofourmis to take part in pioneering heart failure research with Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI)

Biofourmis’ innovative technology to measure patient-centric endpoints to inform future drug development   BOSTON, July 16, 2019 /PRNewswire/ — Biofourmis, a fast-growing global leader in digital therapeutics, has entered a research partnership with the Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI). Biofourmis’ mobile platform BiovitalsHFTM will be leveraged in a study of patients with heart failure […]

Biofourmis Closes $35 Million Series B Financing Round to Advance Artificial Intelligence-Powered Digital Therapeutics Platform

Funding to grow clinically validated solution that combines AI, drug therapies, wearable sensors and smartphone app to deliver better patient outcomes   BOSTON, May 21, 2019 /PRNewswire/ — Biofourmis, a fast-growing leader in digital therapeutics, today announced that it has successfully closed $35 million in Series B financing. The company also announced it will be expanding its Boston office and moving its […]